If you live with polycystic ovary syndrome (PCOS), now PMOS, you probably think of it as a condition that affects your period, your skin, or your ability to get pregnant. But PCOS is a whole-body condition. One of the body systems it can quietly affect is the liver.
Research shows that women with PCOS/PMOS have a higher chance of developing a condition called nonalcoholic fatty liver disease, or NAFLD. In this article, we'll explain what NAFLD is, how it connects to PCOS/PMOS, and what the science says about the shared factors behind both conditions. This is general health education, not a diagnosis or treatment plan for any one person.
What Is PCOS/PMOS, Exactly?
Polycystic ovary syndrome is a common hormonal condition in women of reproductive age. It's usually marked by irregular periods, higher-than-typical levels of androgens (sometimes called "male hormones," though everyone has them), and small fluid-filled sacs on the ovaries.
But PCOS/PMOS isn't only about reproductive hormones. Many women with PCOS also have insulin resistance. This means the body's cells don't respond to insulin as well as they should, so the pancreas has to produce more of it to keep blood sugar steady. Over time, this extra insulin can affect many parts of the body, including the liver.
What Is Nonalcoholic Fatty Liver Disease (NAFLD)?
Nonalcoholic fatty liver disease is a condition where extra fat builds up in the liver, in people who drink little to no alcohol. It's one of the most common liver conditions in the world today.
Most people with NAFLD have no symptoms at all, which is part of why it's often called a "silent" condition. There are two general forms:
- Simple fatty liver (NAFL): Fat has built up in the liver, but there is little or no inflammation or liver damage.
- Nonalcoholic steatohepatitis (NASH): A more advanced form where the liver shows inflammation and damage in addition to fat buildup.
Because NAFLD often has no obvious symptoms, many people don't know they have it until it's found during a routine blood test or imaging for another reason.
Why Are PCOS and Fatty Liver Connected?
This is where the research gets interesting. Multiple studies have found that women with PCOS are more likely to have NAFLD than women without PCOS, even when body weight is similar between groups. Scientists believe a few shared underlying factors help explain this overlap:
Insulin resistance. Insulin resistance is considered a central feature of both PCOS and NAFLD. When cells resist insulin's signal, the liver can respond by producing and storing more fat, which contributes to fatty liver buildup over time.
Excess androgens. PCOS is associated with higher levels of androgens like testosterone. Research suggests that women with PCOS who have higher androgen levels may have an increased likelihood of liver fat accumulation, independent of insulin resistance and body weight, though scientists note this relationship is still being studied and isn't fully settled.
Body fat distribution. Central, or abdominal, body fat is common in PCOS and is also strongly linked to fatty liver. Fat stored around the abdomen behaves differently than fat stored elsewhere and is more metabolically active, which can influence how the liver processes fat and sugar.
Metabolic syndrome overlap. PCOS and NAFLD often travel with other metabolic features, such as higher blood sugar, unfavorable cholesterol levels, and elevated blood pressure. Together, these are sometimes grouped under the term "metabolic syndrome," and researchers see this cluster of factors as a shared thread connecting the two conditions.
Why This Matters for Long-Term Wellness
Understanding this connection matters because both PCOS and NAFLD are linked to broader metabolic and cardiovascular health over the long term. Health researchers have noted that NAFLD is associated with increased risk for cardiovascular disease, and that this risk appears to be even more pronounced in people who also have PCOS.
This doesn't mean every woman with PCOS will develop fatty liver disease, or that everyone with fatty liver disease has PCOS. It simply means the two conditions share biological pathways worth understanding, especially since both can develop without noticeable symptoms in the early stages.
What Can You Do With This Information?
Because NAFLD often has no symptoms, awareness is the first step. If you have PCOS, it may be worth talking with your healthcare provider about routine liver health screening, especially if you have other risk factors like insulin resistance, higher body weight, or a family history of liver or metabolic conditions.
Lifestyle factors that support metabolic health more broadly, such as regular movement, balanced nutrition, and consistent sleep, are commonly studied in connection with both insulin sensitivity and liver fat levels. Research in this area is ongoing, and any changes to your diet, exercise routine, or supplement use should be discussed with a healthcare provider who understands your full health history.
The Bottom Line
PCOS is more than a reproductive condition. It's a hormonal and metabolic condition that can influence organs throughout the body, including the liver. The research connecting PCOS and nonalcoholic fatty liver disease points to shared underlying factors, particularly insulin resistance and excess androgens, rather than one condition directly causing the other.
If you have PCOS, understanding this connection can help you have more informed conversations with your healthcare team about which screenings and lifestyle factors might be relevant to your own health picture.
Sources
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). "Definition & Facts of NAFLD & NASH." National Institutes of Health.
- Rocha, A.L.L., et al. "Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center." Archives of Endocrinology and Metabolism, 2020;64(3):235-42.
- Kumarendran, B., et al. "Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome." Scientific Reports, 2023.
- Macut, D., et al. "Nonalcoholic fatty liver disease and polycystic ovary syndrome." World Journal of Gastroenterology (PMC).
- Zhu, S., et al. "Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease." Cureus/PMC.
